Ph.D., Founder and CEO, Crystal Genetics, Inc.
Dr. Bahram G. Kermani is the Founder and CEO of Crystal Genetics, Inc. He is an expert in the fields of computational biology, genomics and machine learning, and has been responsible for the executive and design roles at the Company. Prior to starting Crystal Genetics, he held various executive and scientific/technical positions at Guardant Health, Complete Genomics, Illumina, and Bell Labs (Lucent Technologies). Dr. Kermani completed a postdoctoral fellowship at Duke University Medical Center. He received his Ph.D. and M.S. in electrical engineering, and biomedical engineering (minor) from North Carolina State University, and received a B.S. in electronics engineering from Amirkabir University of Technology. Dr. Kermani has several peer-reviewed journal publications and book chapters in the areas of genomics, biomedical engineering, and electrical engineering. He holds in excess of 46 patents issued in the United States, Canada, France, United Kingdom, Germany, and Japan.
Presentation Title and Company Description
Clinical Dx Showcase: High-Accuracy Comprehensive and Scalable Genetic Testing
Crystal Genetics is focused on developing methods for achieving high-accuracy, comprehensive and scalable genetic tests. These tests span a wide range of applications, including those with biomarkers for genetic conditions, predispositions, companion diagnostics, and early detection of cancer.